EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Replenishing co‐downregulated mi R ‐100‐5p and mi R ‐125b‐5p in malignant germ cell tumors causes growth inhibition through cell cycle disruption

Marta Ferraresso, Shivani Bailey, Luz Alonso-Crisostomo, Dawn Ward, Christos Panayi, Zachary G L Scurlock, Harpreet K Saini, Stephen P Smith, James C Nicholson, Anton J Enright, Cinzia G Scarpini iD, Nicholas Coleman iD und 1 weitere

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.13757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Marta Ferraresso und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Cambridge, UK. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Germ Cell and Embryonal, Down-Regulation, Cell Cycle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Cambridge Biomedical Research Centre, St. Baldrick's Foundation, Waldmann Fund, Department of Pathology, University of Cambridge.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are short, nonprotein‐coding RNAs, and their expression is dysregulated in malignant germ cell tumors (GCTs). Here, we investigated the causes and consequences of downregulated miR‐99a‐5p/miR‐100‐5p (functionally identical) and miR‐125b‐5p levels in malignant GCTs regardless of age, site, or subtype. Quantitative RT‐PCR was used to assess miR‐99a‐5p/miR‐100‐5p, miR‐125b‐5p, and associated gene expression in malignant GCT tissues/cell lines [seminoma (Sem), yolk sac tumor (YST), embryonal carcinoma (EC)]. Cells were treated with demethylating 5‐azacytidine and pyrosequencing was performed. Combination miR‐100‐5p/miR‐125b‐5p mimic replenishment was used to treat malignant GCT cells. Global messenger RNA (mRNA) targets of the replenished miRNAs were identified and Metascape used to study pathway effects. We found that expression levels of miR‐99a‐5p/miR‐100‐5p and miR‐125b‐5p, their respective pri‐miRNAs, and associated genes from chromosomes 11 and 21 (chr11/chr21) were downregulated and highly correlated in malignant GCT cells. Treatment with 5‐azacytidine caused upregulation of these miRNAs, with pyrosequencing revealing hypermethylation of their chr11/chr21 loci, likely contributing to miR‐100‐5p/miR‐125b‐5p downregulation. Combination miR‐100‐5p/miR‐125b‐5p mimic replenishment resulted in growth inhibition in Sem/YST cells, with miR‐100‐5p/miR‐125b‐5p mRNA targets enriched in downregulated genes, which were involved in cell cycle (confirmed by flow cytometry) and signaling pathways. Knockdown of the miR‐100‐5p/miR‐125b‐5p target tripartite motif containing 71 ( TRIM71 kd) recapitulated miR‐100‐5p/miR‐125b‐5p replenishment, with growth inhibition and cell cycle disruption of Sem/YST/EC cells. Further, replenishment led to reduced lin‐28 homolog A ( LIN28A ) levels and concomitant increases in let‐7 ( MIRLET7B ) tumor suppressor miRNAs, creating a sustained reversion of cell phenotype. In summary, combination miR‐100‐5p/miR‐125b‐5p mimic replenishment or TRIM71 kd caused growth inhibition in malignant GCT cells via cell cycle disruption. Further studies are now warranted, including mimic treatment alongside conventional platinum‐based chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasms, Germ Cell and EmbryonalDown-RegulationCell CycleHumansCell Line, TumorGene Expression Regulation, NeoplasticMaleCell ProliferationAzacitidine

Stichwörter der Autor:innen

germ cell tumorin vitro modelsmRNAmethylationmicroRNAtestis

Substanzen

MicroRNAsMIRN125 microRNA, humanMIRN100 microRNA, humanAzacitidine

Autor:innen und Institutionen

  • Department of Pathology, University of Cambridge, UK.
  • EMBL-European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Department of Paediatrics, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, UK.
  • Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, UK.
  • Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, UK.

ORCID-Profile: Cinzia G Scarpini, Nicholas Coleman, Matthew J Murray

Förderung

  • NIHR Cambridge Biomedical Research Centre
  • St. Baldrick's Foundation
  • Waldmann Fund, Department of Pathology, University of Cambridge
  • CCLG
  • Cancer Research UK
  • Children's Cancer and Leukaemia Group

Zitieren

APA

Ferraresso, M., Bailey, S., Alonso-Crisostomo, L., Ward, D., Panayi, C., Scurlock, Z. G. L., Saini, H. K., Smith, S. P., Nicholson, J. C., Enright, A. J., Scarpini, C. G., Coleman, N., & Murray, M. J. (2025). Replenishing co‐downregulated mi R ‐100‐5p and mi R ‐125b‐5p in malignant germ cell tumors causes growth inhibition through cell cycle disruption. Molecular Oncology. https://doi.org/10.1002/1878-0261.13757

Vancouver

Ferraresso M, Bailey S, Alonso-Crisostomo L, Ward D, Panayi C, Scurlock ZGL, et al. Replenishing co‐downregulated mi R ‐100‐5p and mi R ‐125b‐5p in malignant germ cell tumors causes growth inhibition through cell cycle disruption. Molecular Oncology. 2025. doi:10.1002/1878-0261.13757

BibTeX
@article{Ferraresso2025,
  author = {Ferraresso, Marta and Bailey, Shivani and Alonso-Crisostomo, Luz and Ward, Dawn and Panayi, Christos and Scurlock, Zachary G L and Saini, Harpreet K and Smith, Stephen P and Nicholson, James C and Enright, Anton J and Scarpini, Cinzia G and Coleman, Nicholas and Murray, Matthew J},
  title = {Replenishing co‐downregulated mi R ‐100‐5p and mi R ‐125b‐5p in malignant germ cell tumors causes growth inhibition through cell cycle disruption},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.13757}
}
Kostenlos starten →